IRIS
DE NICOLA, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 19.806
NA - Nord America 9.387
AS - Asia 7.914
SA - Sud America 1.403
AF - Africa 110
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 7
Totale 38.635
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 13.076
US - Stati Uniti d'America 9.274
SG - Singapore 2.817
IE - Irlanda 2.168
CN - Cina 1.829
HK - Hong Kong 1.448
BR - Brasile 1.193
UA - Ucraina 1.165
GB - Regno Unito 909
IT - Italia 704
DE - Germania 643
IN - India 478
VN - Vietnam 345
TR - Turchia 328
FI - Finlandia 320
SE - Svezia 299
KR - Corea 298
GR - Grecia 188
JP - Giappone 100
FR - Francia 90
AR - Argentina 85
AT - Austria 58
BD - Bangladesh 57
CA - Canada 46
BE - Belgio 43
MX - Messico 37
EC - Ecuador 36
CZ - Repubblica Ceca 29
IQ - Iraq 29
NL - Olanda 29
ZA - Sudafrica 29
ID - Indonesia 27
PK - Pakistan 27
ES - Italia 25
CO - Colombia 23
MA - Marocco 21
IR - Iran 17
TN - Tunisia 17
VE - Venezuela 17
CL - Cile 14
PY - Paraguay 14
UZ - Uzbekistan 14
PH - Filippine 13
MY - Malesia 11
PL - Polonia 11
IL - Israele 10
KE - Kenya 10
KZ - Kazakistan 10
LT - Lituania 10
AE - Emirati Arabi Uniti 9
JM - Giamaica 9
UY - Uruguay 9
EU - Europa 8
PE - Perù 8
EG - Egitto 6
SA - Arabia Saudita 6
CH - Svizzera 5
RS - Serbia 5
SC - Seychelles 5
AU - Australia 4
BO - Bolivia 4
ET - Etiopia 4
GE - Georgia 4
KG - Kirghizistan 4
NI - Nicaragua 4
OM - Oman 4
AL - Albania 3
BG - Bulgaria 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
LB - Libano 3
MK - Macedonia 3
NP - Nepal 3
PT - Portogallo 3
RO - Romania 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
TW - Taiwan 3
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DK - Danimarca 2
GA - Gabon 2
HN - Honduras 2
JO - Giordania 2
KH - Cambogia 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PS - Palestinian Territory 2
RW - Ruanda 2
SN - Senegal 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
UG - Uganda 2
AD - Andorra 1
AO - Angola 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
BH - Bahrain 1
Totale 38.614
Salva come PNG Salva come JPEG
Città #
Moscow 4.555
Dublin 2.167
Jacksonville 1.747
Santa Clara 1.508
Hong Kong 1.446
Chandler 1.119
Singapore 1.003
Chicago 473
Bengaluru 437
Princeton 343
Hefei 316
Seoul 289
Medford 279
Wilmington 269
Beijing 214
Ashburn 213
Roxbury 210
Boardman 208
Dallas 191
Ann Arbor 168
San Mateo 157
Falls Church 133
Ho Chi Minh City 128
The Dalles 125
Woodbridge 118
São Paulo 105
New York 101
Munich 96
Istanbul 95
Naples 88
Cambridge 85
Hanoi 83
Bremen 75
Des Moines 70
Nanjing 69
Jinan 62
Caserta 56
Los Angeles 51
Rio de Janeiro 44
Brussels 42
Norwalk 41
Nuremberg 41
Houston 38
Mountain View 35
Shenyang 35
Belo Horizonte 33
Napoli 33
Saint Petersburg 32
Zhengzhou 32
Rome 30
Guangzhou 29
Milan 28
Vienna 28
Brno 27
Tianjin 24
Helsinki 22
Changsha 21
Curitiba 20
Düsseldorf 19
Ercolano 19
Ningbo 19
Brooklyn 18
Nanchang 18
Shanghai 18
Taizhou 18
Campinas 17
Hangzhou 17
Turku 17
Sorocaba 15
Taiyuan 15
Da Nang 14
Falkenstein 14
Haiphong 14
Johannesburg 14
Lanzhou 14
London 14
San Francisco 14
Biên Hòa 13
Dhaka 13
Porto Alegre 13
Quito 13
Auburn Hills 12
Bologna 12
Haikou 12
Jiaxing 12
Seattle 12
Tashkent 12
Buenos Aires 11
Hebei 11
Salvador 11
Boston 10
Brasília 10
Frankfurt am Main 10
Manaus 10
San Jose 10
Tokyo 10
Zanjan 10
Amsterdam 9
Asunción 9
Charlotte 9
Totale 20.049
Salva come PNG Salva come JPEG
Nome #
Ethanol and in-vitro Vascular Reactivity of Rats Mesenteric-Artery 830
A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population 216
Ruolo del refilling plasmatico dopo dialisi alternativa: valutazione dei dati bioimpedenzometrici 181
Reassessment of Ambulatory Blood Pressure Improves Renal Risk Stratification in Nondialysis Chronic Kidney Disease: Long-Term Cohort Study 178
Amino acid loss during dialysis treatment 168
Empagliflozin in Patients with Chronic Kidney Disease 165
Acute and chronic effects of standard hemodialysis and soft hemodiafiltration on interdialytic serum phosphate levels 162
Cardiovascular risk factors and disease management in type 2 diabetic patients with diabetic nephropathy 161
Controversial issues in CKD clinical practice: position statement of the CKD-treatment working group of the Italian Society of Nephrology 161
Acute cyclosporine renal dysfunction reversed by dopamine infusion in healthy subjects 159
L'impiego dell’ Emodiafiltrazione con reinfusione endogena (HFR) nell'infiammazione cronica idiopatica: una possibile alternativa terapeutica? 159
Alterazioni del bilancio idro-elettrolitico nell’insufficienza renale acuta: implicazioni cliniche 159
[Hyperuricaemia and Chronic Kidney Disease] 155
Absence of acute nephrotoxicity with low doses of cyclosporin: experimental study in the rat 154
[Anti-diabetics and chronic kidney disease] 154
[Iron deficiency in ND-CKD: from diagnosis to treatment] 153
Conversion of darbepoetin to low doses of CERA maintains hemoglobin levels in non-dialysis chronic kidney disease patients 152
Daily nutrient intake in hemodialysis. 151
Assessment of Achieved Clinic and Ambulatory Blood Pressure Recordings and Outcomes During Treatment in Hypertensive Patients With CKD: A Multicenter Prospective Cohort Study 150
Acute increase in plasma osmolality as a cause of hyperkalemia in patients with renal failure 147
CHRONIC CYCLOSPORINE A NEPHROTOXICITY - A MORPHOLOGICAL AND FUNCTIONAL-STUDY IN RATS 146
[Clinical experience with ferric carboxymaltose in non-dialysis chronic kidney disease] 146
Antiproteinuric Response to Dual Blockade of RAS in Primary Glomerulonephritis: Meta-Analysis and Meta-Regression 145
Independent role of underlying kidney disease on renal prognosis of patients with chronic kidney disease under nephrology care 144
Assessment of achieved clinic and ambulatory BP recordings and outcomes during treatment in hypertensive patients with CKD: a multicenter prospective cohort study. 144
Antiproteinuric response to add-on aliskiren in proteinuric patients treated with dual blockade of the renin-angiotensin system: a 12-month prospective uncontrolled study 143
Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy 143
Cardiorenal prognosis by residual proteinuria level in diabetic chronic kidney disease: pooled analysis of four cohort studies 142
Achievement of target blood pressure levels in chronic kidney disease: a salty question ? 141
Assesement of achieved clinic and ambulatory blood pressure recordings and outcomes during treatment in hypertensive patients wih CKD: a multicenter prospective cohort study 139
Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension 139
Area Deprivation and Risk of Death and CKD Progression: Long-Term Cohort Study in Patients under Unrestricted Nephrology Care 138
Burden of resistant hypertension in hypertensive patients with non-dialysis chronic kidney disease 137
Abnormalities of bioimpedance measures in overweight and obese hemodialyzed patients 137
[Epidemiology and prognosis of chronic kidney disease in Italy] 137
Clinical management of the patient affected with acute renal failure (ARF) secondary to volume depletion 136
Acute renal and immunological effects of low-dose cyclosporin in humans 136
Mesangial hypercellularity predicts antiproteinuric response to dual blockade of RAS in primary glomerulonephritis 136
[Census of the renal and dialysis units by Italian Society of Nephrology: structure and organization for renal patient assistance in Italy (2014-2015)] 136
[Peritoneal dialysis catheter infection with abscess of the abdominal wall in a ADPKD patient] 136
Acute cyclosporine A nephrotoxicity 135
15-year-change of phenotype and prognosis in non-dialysis CKD patients referred to a nephrology clinic 134
Alterations of hydro-electrolyte balance in acute renal failure: clinical implications 134
A new diuretic: the Atrial Natriuretic Peptide 131
Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM) 131
Blood pressure variability, mortality, and cardiovascular outcomes in CKD patients 131
Management of hypertension in patients with CKD: differences between primary and tertiary care settings 129
Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics 128
[Hyperkalemia treatment in chronic kidney disease patients: overview on new cation exchange resins and possible therapeutic approaches] 128
Epidemiology of chronic kidney disease in Italy: the CARHES study 126
Ruolo dell’ossido nitrico nella regolazione dell’emodinamica glomerulare 126
Prevalence and Prognosis of Mild Anemia in Non-Dialysis CKD: A Prospective Cohort Study in Outpatient Renal Clinics 126
Acute effects of low-dose cyclosporine on renal function in normal subjects 126
Short-term blood pressure variability in nondialysis chronic kidney disease patients: correlates and prognostic role on the progression of renal disease 126
Acute effects of cyclosporine on glomerular dynamics--micropuncture study in the rat 126
Comprehensive audit of antihypertensive treatment in patients with chronic renal insufficiency (CRI): The Italian Multicentre survey 125
Chronic Hyperkaliemia in Chronic Kidney Disease: An Old Concern with New Answers 123
Management of hypertension in chronic kidney disease 123
Role of paracalcitol in the management of non-dialysis CKD: state of art and unmeet needs. 123
Prevalence and cardiovascular risk profile of chronic kidney disease in Italy: results of the 2008-12 National Health Examination Survey 122
Renal Disease 122
Italian audit on therapy of hypertension in chronic kidney disease: the TABLE-CKD study 121
Management of hypertension in chronic kidney disease: the Italian multicenter study. 121
Disfunzione renale nell’anziano: processo fisiologico o malattia? 121
Heart Failure in chronic kidney disease: from epidemiology to therapy. 120
Prognostic role of LDL cholesterol in non-dialysis chronic kidney disease: Multicenter prospective study in Italy 120
AMBULATORY BLOOD PRESSURE (ABP) AND RESISTANT HYPERTENSION (RH): TWO INCREMENTAL PREDICTORS OF LONG TERM COMPLICATIONS IN NON-DIALYSIS CKD 120
Epidemiology of CKD Regression in Patients under Nephrology Care 120
Effects of efficiency and length of acetate-free biofiltration session on postdialysis solute rebound 119
Maximal suppression of renin-angiotensin system in nonproliferative glomerulonephritis 119
High cardiovascular risk in patients with Type 2 diabetic nephropathy: the predictive role of albuminuria and glomerular filtration rate. The NID-2 Prospective Cohort Study. 119
Types of erythropoiesis-stimulating agents and risk of end-stage kidney disease and death in patients with non-dialysis chronic kidney disease 119
Anemia: A Connection Between Heart Failure and Kidney Failure 119
Very low protein diet supplemented with ketoanalogs improves blood pressure control in chronic kidney disease 118
Epidemiology of chronic kidney disease in Italy 118
Rebound post-dialitico della fosforemia: implicazioni patogenetiche e cliniche 118
Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure 117
Effect of hemodiafiltration with endogenous reinfusion on overt idiopathic chronic inflammation in maintenance hemodialysis patients: A multicenter longitudinal study. 117
Prevalence and clinical correlates of white coat hypertension in chronic kidney disease 117
Waist: hip ratio is a better predictor of cardiovascular risk than BMI in patients with moderate CKD 117
Sodium removal by peritoneal dialysis: a systematic review and meta-analysis 117
Very low-protein diet plus ketoacids in chronic kidney disease and risk of death during end-stage renal disease: an historical, cohort, controlled study. 116
Role of inhibition of atrial natriuretic factor release in the down-regulation of salt excretion 116
Epidemiology of chronic kidney disease in Italy. J Nephrol 2010;23 (Suppl 15):S16-22 116
Epidemiology of chronic kidney disease in Italy: current state and contribution of the CARHES study. 116
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy 116
Antiproteinuric effect of paricalcitol in kidney transplant recipients with severe proteinuria: a prospective cohort study 115
Prevalence and Prognostic Role of Resistant Hypertension in Chronic Kidney Disease Patients 115
Anaemia management in non-dialysis chronic kidney disease: flexibility of target to target stability? 115
Reversibility of acute cyclosporine renal impairment by dopamine in healthy subjects 115
Prognosis of CKD Patients Receiving Outpatient Nephrology Care in Italy 115
Long-term visit-to-visit office blood pressure variability increases the risk of adverse cardiovascular outcomes in patients with chronic kidney disease. 115
Stage 5-CKD under nephrology care: to dialyze or not to dialyze, that is the question 115
Epidemiologia e Prognosi della Malattia Renale Cronica in Italia 114
Efficacy of erythropoietin on dialysis in patients with Beta-Thalassemia Minor 114
Inibizione dell’angiotensina II e proteinuria in pazienti con glomerulonefrite IgA mesangiale 114
Anaemia management in non-dialysis chronic kidney disease (CKD) patients: a multicentre prospective study in renal clinics. 114
Hyponatremia secondary to inappropriate antidiuretic hormone secretion. 113
Ferric carboxymatose in non-hemodialysis ckd patients: A longitudinal cohort study 113
Epidemiology of chronic kidney disease in Italy: current situation and contribution of the CARHES study 112
Totale 13.947
Salva come PNG Salva come JPEG
Categoria #
all - tutte 133.573
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 133.573
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.287 0 0 0 0 0 12 325 279 17 340 250 64
2021/20222.291 188 42 43 82 726 19 44 56 83 145 213 650
2022/20234.441 422 137 318 363 398 342 10 253 1.992 37 75 94
2023/20241.699 150 49 74 172 613 96 38 30 34 32 125 286
2024/20255.897 16 84 81 184 940 893 821 499 637 998 410 334
2025/202618.575 887 1.204 1.168 1.078 1.769 12.469 0 0 0 0 0 0
Totale 39.085